Related Experiment Video
Updated: Jun 23, 2025

10:37
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
132
High-Dimensional Fixed Effects Profiling Models and Applications in End-Stage Kidney Disease Patients: Current State
Danh V Nguyen1, Qi Qian2, Amy S You1
1Department of Medicine, University of California Irvine, Orange, CA 92868, USA.
Summary
Fixed effects (FE) profiling models enhance the evaluation of dialysis facilities for patient outcomes like hospital readmissions. These models offer improved accuracy and account for the specific needs of end-stage kidney disease patients.
Area of Science:
- Health Services Research
- Biostatistics
- Nephrology
Background:
- Healthcare provider profiling is crucial for patient outcomes.
- Fixed effects (FE) models offer advantages over random effects (RE) models.
- End-stage kidney disease (ESKD) patients have unique care needs.
Purpose of the Study:
- Review current FE methodologies for ESKD patient profiling.
- Illustrate FE model applications in dialysis facility evaluation.
- Identify future research challenges in FE profiling for ESKD.
Main Methods:
- Review of existing FE profiling methodologies.
- Application of FE models to ESKD patient data.
- Analysis of standardized dynamic readmission ratio (SDRR) and standardized event ratio (SER).
Main Results:
- FE models improve the identification of under-performing dialysis facilities.
- FE models can identify facility characteristics linked to readmissions.
- FE models are applicable to longitudinal patient hospitalizations and recurrent adverse events.
Conclusions:
- FE profiling models are valuable tools for evaluating dialysis facilities in the ESKD population.
- Further methodological and clinical research is needed to optimize FE models.
- FE models enhance the understanding of factors influencing patient outcomes in ESKD care.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Renal Failure: Dose Adjustments
80
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
80
Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129

